rss
Thorax 2005;60:622
  • Miscellaneous

N-Acetylcysteine and disease progression in COPD

  1. K Satkunam
  1. Specialist Registrar, Newham University Hospital, London, UK; karnan@doctors.org.uk

    ▴ Decramer M, Rutten-van Mölken M, Dekhuijzen PR, et al. Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomized placebo-controlled trial. Lancet2005;365:1552–60

    It is known that oxidative stress plays an important role in the pathogenesis of chronic obstructive pulmonary disease (COPD). In this study the anti-oxidant N-acetylcysteine (NAC) was used to assess whether this drug could …

    [Full text of this article]

    This Article

    1. Extract
    2. Full text
    3. PDF

    Social bookmarking

    Register for free content


    Free sample
     This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of Thorax.
    View free sample issue >>

    Free archive
    The full back archive is now available for Thorax. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
    Register to access the free archive >>

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.